# ENX-205 SAD/PET Study in Healthy Adults

> **NCT07253246** · PHASE1 · RECRUITING · sponsor: **Engrail Therapeutics INC** · enrollment: 60 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ENX-205
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07253246
- **Lead sponsor:** Engrail Therapeutics INC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-23
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07253246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07253246, "ENX-205 SAD/PET Study in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07253246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*